Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.
Last updated: 2025-12-17 20:59:51 ET
No hourly mention data available.
Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.
Canada logged its first trade surplus in eight months in September as exports rebounded and domestic demand showed signs of softening.
The number of Americans filing new claims for unemployment benefits rose last week but stayed well within the range that has prevailed over the past y...
Gov. Tiff Macklem acknowledged positive developments but said challenges remain and growth is expected to be ‘fairly modest’.
Investors were bracing for the Federal Reserve’s final interest-rate decision of 2025 on Wednesday, with history showing that the S&P 500 index has ...